Revolutionary breakthroughs in genetic science have transformed what was once a futuristic approach into an attainable shift in the medical paradigm. Today’s tools enable diagnosis and individualized precision treatments at the genetic level, bringing us closer to single-intervention cures. Join this collaborative discussion between patient advocacy, the Advanced Research Projects Agency for Health (ARPA-H), and industry as they discuss the future potential of high-impact biotech research to build healthier lives for everyone. Speakers will highlight the fast and nimble ways they aim to create a robust field of precision genetic medicines and underscore the potential for collaborative public-private partnerships to break down barriers for early-stage companies, accelerating their development and commercialization path.